|
| 37364803 | Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis. | Am J Obstet Gynecol | 2024 |
| 35260474 | UK recommendations for <i>SDHA</i> germline genetic testing and surveillance in clinical practice. | J Med Genet | 2023 |
| 37178708 | Utility of polygenic risk scores in UK cancer screening: a modelling analysis. | Lancet Oncol | 2023 |
| 37031776 | Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018. | J Am Acad Dermatol | 2023 |
| 36854461 | Realistic expectations are key to realising the benefits of polygenic scores. | BMJ | 2023 |
| 36744544 | Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group. | Br J Haematol | 2023 |
| 36572524 | Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records. | J Med Genet | 2023 |
| 36765408 | Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis. | Breast Cancer Res | 2023 |
| 34740923 | Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score. | Clin Cancer Res | 2022 |
| 35805038 | Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> Mutation. | Cancers (Basel) | 2022 |
| 35700037 | Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35460607 | Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. | Am J Hum Genet | 2022 |
| 35715636 | Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing. | Br J Cancer | 2022 |
| 35657381 | Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK). | Genet Med | 2022 |
| 35868849 | A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot. | J Med Genet | 2022 |
| 36115878 | Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis. | Br J Cancer | 2022 |
| 34906457 | Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD. | Genet Med | 2022 |
| 32855306 | Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study. | Gut | 2021 |
| 33737296 | Genetically Inferred Telomere Length and Testicular Germ Cell Tumor Risk. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33558336 | Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response. | Cancer Res | 2021 |
| 33578357 | Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. | Eur J Cancer | 2021 |
| 34758253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 |
| 34021222 | Will polygenic risk scores for cancer ever be clinically useful? | NPJ Precis Oncol | 2021 |
| 34230640 | Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes. | Genet Med | 2021 |
| 33222309 | Tumor-only sequencing for oncology management: Germline-focused analysis and implications. | Genes Chromosomes Cancer | 2021 |
| 33453764 | Effect of COVID-19 on colorectal cancer care in England. | Lancet Gastroenterol Hepatol | 2021 |
| 33208383 | Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations. | J Med Genet | 2021 |
| 32266967 | Primrose syndrome: Characterization of the phenotype in 42 patients. | Clin Genet | 2020 |
| 31949161 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. | Nat Commun | 2020 |
| 32107557 | Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D. | J Natl Cancer Inst | 2020 |
| 33203640 | Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. | BMJ Open | 2020 |
| 32742705 | Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. | R Soc Open Sci | 2020 |
| 32601456 | Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. | Nat Rev Clin Oncol | 2020 |
| 32620889 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. | Nat Commun | 2020 |
| 32702311 | Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. | Lancet Oncol | 2020 |
| 32668122 | Etiologic Index - A Case-Only Measure of <i>BRCA1/2</i>-Associated Cancer Risk. | N Engl J Med | 2020 |
| 32366847 | Genomic landscape of platinum resistant and sensitive testicular cancers. | Nat Commun | 2020 |
| 32555420 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement. | Nat Rev Clin Oncol | 2020 |
| 32152486 | Peridiagnostic and cascade cancer genetic testing. | Nat Rev Clin Oncol | 2020 |
| 32442581 | Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. | Ann Oncol | 2020 |
| 30586678 | Rapid reversal of clinical down-classification of a BRCA1 splicing variant avoiding psychological harm. | Clin Genet | 2019 |
| 31748747 | Genetic predisposition to mosaic Y chromosome loss in blood. | Nature | 2019 |
| 31018999 | Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs). | J Med Genet | 2019 |
| 30962250 | Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. | J Med Genet | 2019 |
| 30542102 | Publisher Correction: Cancer genetics, precision prevention and a call to action. | Nat Genet | 2019 |
| 30670737 | Mendelian randomization provides support for obesity as a risk factor for meningioma. | Sci Rep | 2019 |
| 29256490 | Testicular cancer in 2017: Sequencing advances understanding. | Nat Rev Urol | 2018 |
| 29935977 | Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology. | Eur Urol | 2018 |
| 30032180 | Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". | J Clin Endocrinol Metab | 2018 |
| 29618007 | Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibility. | Hum Reprod | 2018 |